Patent · US Active

Use of prodigiosin in resisting potyvirus

US11375718B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 25, 2020
Grant dateJul 5, 2022
Priority date
Expiry dateMar 4, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA01P21/00
  • WIPO fieldBasic materials chemistry
  • WIPO sectorChemistry

Abstract

The present invention belongs to the technical field of application of microbial secondary metabolites, and particularly relates to novel use of prodigiosin in resisting potato virus Y. Application of prodigiosin in preparing a medicine for preventing and controlling potato virus Y. The medicine for preventing and controlling the potyvirus is a liquid or solid preparation containing prodigiosin. It is clarified that PVY promotes its own replication and infection by recruiting host factor Hsp70 in the process of infecting the host, realizing virus infection and spread. Hsp70 plays an important role in the infection and replication of plant viruses. Based on the above results, it is further clarified that prodigiosin treatment can significantly increase the ubiquitination level of the plant host, promote the ubiquitination of HSP70 protein of the host, degrade or inhibit the expression of Hsp70 protein, activate the natural immune activity of the host plant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.